Successful Innovation in Key Markets
Haleon has been rolling out successful innovations, particularly in their clinical range, including Nasal Mist on Otrivin and Panadol Dual Action. The company is also focusing on driving growth in India, Central Europe, and China.
Strong Performance in Oral Health
Haleon's Oral Health segment is performing well, with market share gains and strong growth in the U.S., gaining 0.5 share point in the first half.
Improved Gross Margin and Cash Flow
The company reported an improvement in gross margin by 160 basis points and strong cash flow, which has enabled continued investment in A&P and R&D.
Positive Volume Growth in EMEA, LatAm, and APAC
Volume growth accelerated in Q2 for EMEA and LatAm from 0.5% to 1.6% and for Asia Pac from 3.3% to 3.9%.